Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus Macaques

被引:42
作者
Bonaldo, Myrna C. [5 ]
Martins, Mauricio A. [1 ]
Rudersdorf, Richard [1 ]
Mudd, Philip A. [1 ]
Sacha, Jonah B. [1 ]
Piaskowski, Shari M. [1 ]
Costa Neves, Patricia C. [5 ]
Veloso de Santana, Marlon G. [5 ]
Vojnov, Lara [1 ]
Capuano, Saverio, III [2 ]
Rakasz, Eva G. [1 ,2 ]
Wilson, Nancy A. [1 ,2 ]
Fulkerson, John [3 ]
Sadoff, Jerald C. [3 ]
Watkins, David I. [1 ,2 ]
Galler, Ricardo [4 ]
机构
[1] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA
[2] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53711 USA
[3] Aeras Global TB Vaccine Fdn, Rockville, MD USA
[4] Inst Tecnol Imunobiol, Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil
[5] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil
关键词
ANKARA BOOST REGIMEN; HIV-1; VACCINE; DISEASE PROGRESSION; VIRAL REPLICATION; CHALLENGE; IMMUNITY; MONKEYS; LYMPHOCYTES; PROTECTION; VECTORS;
D O I
10.1128/JVI.02255-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Here we describe a novel vaccine vector for expressing human immunodeficiency virus (HIV) antigens. We show that recombinant attenuated yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 Gag sequences can be used as a vector to generate SIV-specific CD8(+) T-cell responses in the rhesus macaque. Priming with recombinant BCG expressing SIV antigens increased the frequency of these SIV-specific CD8(+) T-cell responses after recombinant YF17D boosting. These recombinant YF17D-induced SIVspecific CD8(+) T cells secreted several cytokines, were largely effector memory T cells, and suppressed viral replication in CD4(+) T cells.
引用
收藏
页码:3699 / 3706
页数:8
相关论文
共 42 条
[1]   Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D [J].
Abbink, Peter ;
Lemckert, Angelique A. C. ;
Ewald, Bonnie A. ;
Lynch, Diana M. ;
Denholtz, Matthew ;
Smits, Shirley ;
Holterman, Lennart ;
Damen, Irma ;
Vogels, Ronald ;
Thorner, Anna R. ;
O'Brien, Kara L. ;
Carville, Angela ;
Mansfield, Keith G. ;
Goudsmit, Jaap ;
Havenga, Menzo J. E. ;
Barouch, Dan H. .
JOURNAL OF VIROLOGY, 2007, 81 (09) :4654-4663
[2]   Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication [J].
Allen, TM ;
Mortara, L ;
Mothé, BR ;
Liebl, M ;
Jing, PC ;
Calore, B ;
Piekarczyk, M ;
Ruddersdorf, R ;
O'Connor, DH ;
Wang, X ;
Wang, CX ;
Allison, DB ;
Altman, JD ;
Sette, A ;
Desrosiers, RC ;
Sutter, G ;
Watkins, DI .
JOURNAL OF VIROLOGY, 2002, 76 (08) :4108-4112
[3]   Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen [J].
Allen, TM ;
Vogel, TU ;
Fuller, DH ;
Mothé, BR ;
Steffen, S ;
Boyson, JE ;
Shipley, T ;
Fuller, J ;
Hanke, T ;
Sette, A ;
Altman, JD ;
Moss, B ;
McMichael, AJ ;
Watkins, DI .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4968-4978
[4]   Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection [J].
Allen, TM ;
Jing, PC ;
Calore, B ;
Horton, H ;
O'Connor, DH ;
Hanke, T ;
Piekarczyk, M ;
Ruddersdorf, R ;
Mothé, BR ;
Emerson, C ;
Wilson, N ;
Lifson, JD ;
Belyakov, IM ;
Berzofsky, JA ;
Wang, CX ;
Allison, DB ;
Montefiori, DC ;
Desrosiers, RC ;
Wolinsky, S ;
Kunstman, KJ ;
Altman, JD ;
Sette, A ;
McMichael, AJ ;
Watkins, DI .
JOURNAL OF VIROLOGY, 2002, 76 (20) :10507-10511
[5]   Tuberculosis vaccine research: the impact of immunology [J].
Barker, Lewellys F. ;
Brennan, Michael J. ;
Rosenstein, Peri K. ;
Sadoff, Jerald C. .
CURRENT OPINION IN IMMUNOLOGY, 2009, 21 (03) :331-338
[6]   Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIVmac251:: Dependence on route of challenge exposure [J].
Benson, J ;
Chougnet, C ;
Robert-Guroff, M ;
Montefiori, D ;
Markham, P ;
Shearer, G ;
Gallo, RC ;
Cranage, M ;
Paoletti, E ;
Limbach, K ;
Venzon, D ;
Tartaglia, J ;
Franchini, G .
JOURNAL OF VIROLOGY, 1998, 72 (05) :4170-4182
[7]   Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus [J].
Bonaldo, MC ;
Garratt, RC ;
Caufour, PS ;
Freire, MS ;
Rodrigeus, MM ;
Nussenzweig, RS ;
Galler, R .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 315 (04) :873-885
[8]   Construction and characterization of recombinant flaviviruses bearing insertions between E and NSI genes [J].
Bonaldo, Myrna C. ;
Mello, Samanta M. ;
Trindade, Gisela F. ;
Rangel, Aymara A. ;
Duarte, Adriana S. ;
Oliveira, Prisciliana J. ;
Freire, Marcos S. ;
Kubelka, Claire F. ;
Galler, Ricardo .
VIROLOGY JOURNAL, 2007, 4 (1)
[9]   Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial [J].
Buchbinder, Susan P. ;
Mehrotra, Devon V. ;
Duerr, Ann ;
Fitzgerald, Daniel W. ;
Mogg, Robin ;
Li, David ;
Gilbert, Peter B. ;
Lama, Javier R. ;
Marmor, Michael ;
del Rio, Carlos ;
McElrath, M. Juliana ;
Casimiro, Danilo R. ;
Gottesdiener, Keith M. ;
Chodakewitz, Jeffrey A. ;
Corey, Lawrence ;
Robertson, Michael N. .
LANCET, 2008, 372 (9653) :1881-1893
[10]   HIV vaccine design and the neutralizing antibody problem [J].
Burton, DR ;
Desrosiers, RC ;
Doms, RW ;
Koff, WC ;
Kwong, PD ;
Moore, JP ;
Nabel, GJ ;
Sodroski, J ;
Wilson, IA ;
Wyatt, RT .
NATURE IMMUNOLOGY, 2004, 5 (03) :233-236